• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[雌激素诱导蛋白2(pS2)与乳腺癌]

[pS2 protein and breast cancer].

作者信息

Torre E A, Fulco R A

机构信息

Istituto Nazionale per la Ricerca sul Cancro, Genova.

出版信息

Minerva Ginecol. 1995 Dec;47(12):553-6.

PMID:8720977
Abstract

pS2 is a small protein (7000 daltons) that is prevalently expressed in human breast cancer positive for estrogen receptors: protein is, in fact, induced by estrogen stimulation. Studies indicate that pS2 protein is a marker for hormone-dependent breast tumors and that its expression is helpful in the prognosis. The presence of pS2, in fact, besides being associated in 96% of the cases to the positivities for estrogen receptors, is associated with longer overall, and disease free, survival. The pS2 protein is also expressed in normal stomach mucosa; its physiological function is unknown.

摘要

pS2是一种小蛋白(7000道尔顿),在雌激素受体阳性的人类乳腺癌中普遍表达:事实上,该蛋白是由雌激素刺激诱导产生的。研究表明,pS2蛋白是激素依赖性乳腺肿瘤的一个标志物,其表达有助于预后判断。实际上,pS2的存在除了在96%的病例中与雌激素受体阳性相关外,还与更长的总生存期和无病生存期相关。pS2蛋白也在正常胃黏膜中表达;其生理功能尚不清楚。

相似文献

1
[pS2 protein and breast cancer].[雌激素诱导蛋白2(pS2)与乳腺癌]
Minerva Ginecol. 1995 Dec;47(12):553-6.
2
The pS2 gene, mRNA, and protein: a potential marker for human breast cancer.pS2基因、信使核糖核酸及蛋白质:一种潜在的人类乳腺癌标志物。
Cancer Cells. 1990 Aug-Sep;2(8-9):269-74.
3
[Immunohistochemical detection of pS2 protein in paraffin sections of breast carcinoma tissue. Comparison with results of an immunoradiometry assay].[乳腺癌组织石蜡切片中pS2蛋白的免疫组织化学检测。与免疫放射分析结果的比较]
Pathologe. 1995 Jul;16(4):278-84. doi: 10.1007/s002920050102.
4
[Breast carcinoma: evaluation of hormone receptors and pS2, erb-B2, P-glycoprotein and Ki-67 markers].[乳腺癌:激素受体及pS2、erb-B2、P-糖蛋白和Ki-67标志物的评估]
J Med Liban. 1996;44(1):10-5.
5
pS2 expression and response to hormonal therapy in patients with advanced breast cancer.晚期乳腺癌患者中pS2的表达及对激素治疗的反应
Cancer Res. 1991 Jan 15;51(2):624-8.
6
CAM26 cytosol levels seem to be correlated with pS2 expression in breast cancer.CAM26胞浆水平似乎与乳腺癌中pS2的表达相关。
Int J Biol Markers. 1993 Jan-Mar;8(1):25-6.
7
[Analysis of the cytosolic content of the pS2 protein in breast cancer].[乳腺癌中pS2蛋白胞质含量的分析]
Rev Esp Med Nucl. 2002 Feb;21(1):28-33. doi: 10.1016/s0212-6982(02)72029-6.
8
Clinical significance of the estrogen regulated pS2 protein in mammary tumors.
Crit Rev Oncol Hematol. 1993 Aug;15(1):13-21. doi: 10.1016/1040-8428(93)90017-x.
9
PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.乳腺癌中的PS2——类固醇受体状态的替代或补充工具?446例病例评估
Br J Cancer. 1993 Aug;68(2):374-9. doi: 10.1038/bjc.1993.343.
10
Specific oncological contribution of cathepsin D and pS2 in human breast cancer: their relationship with TNM status, estradiol receptors, epidermal growth factor receptor and neu amplification.
Clin Chim Acta. 1996 Mar 29;247(1-2):89-103. doi: 10.1016/0009-8981(95)06247-5.